T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Broadcom
AVGO
|
+$3.01B |
| 2 |
Gilead Sciences
GILD
|
+$1.25B |
| 3 |
Accenture
ACN
|
+$1.09B |
| 4 |
XYZ
Block, Inc.
XYZ
|
+$1.06B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.84B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.47B |
| 4 |
Eli Lilly
LLY
|
+$1.43B |
| 5 |
Tesla
TSLA
|
+$1.4B |
Sector Composition
| 1 | Technology | 30.49% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.27% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
ITT
ITT
$14.2B
| $7.72M | ﹤0.01% |
59,736
+5,301
| +10% | +$685K |
|
1152
Parsons
PSN
$8.05B
| $7.65M | ﹤0.01% |
129,177
+101,387
| +365% | +$6M |
|
1153
Caesars Entertainment
CZR
$5.32B
| $7.58M | ﹤0.01% |
303,294
+812
| +0.3% | +$20.3K |
|
1154
Rivian
RIVN
$17.4B
| $7.51M | ﹤0.01% |
602,668
+54,070
| +10% | +$673K |
|
1155
TD Synnex
SNX
$12.3B
| $7.46M | ﹤0.01% |
71,757
-5,298
| -7% | -$551K |
|
1156
Crown Holdings
CCK
$11.1B
| $7.45M | ﹤0.01% |
83,452
+6,100
| +8% | +$545K |
|
1157
Oric Pharmaceuticals
ORIC
$1.06B
| $7.44M | ﹤0.01% |
1,332,860
+37,835
| +3% | +$211K |
|
1158
Corcept Therapeutics
CORT
$7.52B
| $7.41M | ﹤0.01% |
64,892
+10,139
| +19% | +$1.16M |
|
1159
WisdomTree
WT
$2.04B
| $7.36M | ﹤0.01% |
825,202
-91,455
| -10% | -$816K |
|
1160
EyePoint Pharmaceuticals
EYPT
$937M
| $7.34M | ﹤0.01% |
1,354,014
-790,733
| -37% | -$4.29M |
|
1161
UGI
UGI
$7.12B
| $7.34M | ﹤0.01% |
221,823
+14,572
| +7% | +$482K |
|
1162
Essential Utilities
WTRG
$10.5B
| $7.33M | ﹤0.01% |
185,445
+12,281
| +7% | +$486K |
|
1163
Doximity
DOCS
$13.5B
| $7.33M | ﹤0.01% |
126,217
-54,526
| -30% | -$3.16M |
|
1164
Kaspi.kz JSC
KSPI
$16.2B
| $7.28M | ﹤0.01% |
78,357
+6,297
| +9% | +$585K |
|
1165
Allison Transmission
ALSN
$7.33B
| $7.27M | ﹤0.01% |
75,960
+20,727
| +38% | +$1.98M |
|
1166
Ally Financial
ALLY
$13.3B
| $7.25M | ﹤0.01% |
198,645
+4,653
| +2% | +$170K |
|
1167
RH
RH
$4.32B
| $7.24M | ﹤0.01% |
30,883
-476,430
| -94% | -$112M |
|
1168
Bio-Rad Laboratories Class A
BIO
$7.64B
| $7.18M | ﹤0.01% |
29,475
+331
| +1% | +$80.6K |
|
1169
Flex
FLEX
$21.4B
| $7.18M | ﹤0.01% |
216,956
+39,367
| +22% | +$1.3M |
|
1170
SouthState Bank Corporation
SSB
$10.1B
| $7.08M | ﹤0.01% |
76,252
+20,150
| +36% | +$1.87M |
|
1171
Omega Healthcare
OHI
$12.4B
| $7.08M | ﹤0.01% |
185,744
+19,013
| +11% | +$724K |
|
|
SGI
1172
Somnigroup International Inc.
SGI
$17.9B
| $7.07M | ﹤0.01% |
118,056
+14,320
| +14% | +$858K |
|
|
CNH
1173
CNH Industrial
CNH
$13.7B
| $7.01M | ﹤0.01% |
570,363
+58,325
| +11% | +$716K |
|
1174
First Horizon
FHN
$11.3B
| $6.99M | ﹤0.01% |
359,685
+37,473
| +12% | +$728K |
|
1175
Freshpet
FRPT
$2.64B
| $6.96M | ﹤0.01% |
83,615
-4,532
| -5% | -$377K |
|